Spectral frequency index monitoring during propofol-remifentanil and propofol-alfentanil total intravenous anaesthesia

The aim of this study was to evaluate the usefulness of spectral frequency index (SFx) monitoring to assess the depth of anaesthesia during propofol-opioid total intravenous anaesthesia (TIVA). Thirty-three patients scheduled for laparoscopic cholecystectomy under propofol TIVA were prospectively an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:CNS drugs 2007-01, Vol.21 (2), p.165-171
Hauptverfasser: ZABA, Zbigniew, BIENERT, Agnieszka, DROBNIK, Leon, DYDERSKI, Stanislaw, KUSZA, Krzysztof
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 171
container_issue 2
container_start_page 165
container_title CNS drugs
container_volume 21
creator ZABA, Zbigniew
BIENERT, Agnieszka
DROBNIK, Leon
DYDERSKI, Stanislaw
KUSZA, Krzysztof
description The aim of this study was to evaluate the usefulness of spectral frequency index (SFx) monitoring to assess the depth of anaesthesia during propofol-opioid total intravenous anaesthesia (TIVA). Thirty-three patients scheduled for laparoscopic cholecystectomy under propofol TIVA were prospectively and randomly allocated to receive either remifentanil (bolus of 1.0 microg/kg, followed by continuous infusion from 0.25 to 0.05 microg/kg/min) [n = 18] or alfentanil (bolus of 10 microg/kg, followed by continuous infusion from 2.0 to 0.5 microg/kg/min) [n = 15]. EEG activity was monitored to achieve the desired depth of anaesthesia, and intravenous propofol was titrated to keep the SFx at 70-80%. The remifentanil and alfentanil groups were compared in relation to the plasma propofol concentration required for an adequate level of hypnosis during maintenance of anaesthesia, Pearson correlation coefficient for the relationship between the plasma propofol concentration and SFx values, recovery parameters, and recall of events during anaesthesia. The study groups were comparable with regard to demographic characteristics, type and duration of surgery, and time to resumption of spontaneous ventilation. No evidence of explicit recall was noted. The mean plasma propofol concentration required for an adequate level of hypnosis during maintenance of anaesthesia was significantly higher in the alfentanil group (3.20 microg/mL) compared with the remifentanil group (2.17 microg/L) [p < 0.05]. In both groups, the Pearson correlation coefficient test showed a linear correlation between SFx values and propofol concentration in the studied propofol concentration range. The mean time to orientation for name and place was significantly shorter (p < 0.05), the mean propofol concentration at orientation for name and place and at the resumption of spontaneous ventilation timepoints was significantly lower (both p < 0.01), and the mean SFx value at resumption of spontaneous ventilation timepoint was significantly higher (p < 0.01) in the remifentanil group. As SFx is linearly related to plasma propofol concentration, this index may be used to measure anaesthetic effect during propofol anaesthesia. The results of this clinical trial are consistent with a previous computer-simulated opioid-propofol model with regard to intraoperative and recovery variables, although the recovery occurred at different propofol concentration and SFx values.
doi_str_mv 10.2165/00023210-200721020-00006
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_68985654</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A199865973</galeid><sourcerecordid>A199865973</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-736f024da2708e15ed70e8541fc94e70f772ad22614ad7bcd788c9e5fdf6cf913</originalsourceid><addsrcrecordid>eNqFkV1rFTEQhoMotlb_giyI3m1Nsvm8LMUvKHihXoc0mdTIbnJM9hT7752ec-xBECQXE948M7yTl5CB0XPOlHxLKeUTZ3TklGqsnI4oUfWInDKm7cjsJB7v7nzUVOgT8qz3H0iISamn5AR1I6jVp-T2ywbC2vw8pAY_t1DC3ZBLhF_DUktea8vlZojbXdm0uqmpzmODJScoqy95HnyJxxc_P-hrXXFqLjj8FkrddiQ99PU79OyfkyfJzx1eHOoZ-fb-3dfLj-PV5w-fLi-uxiAEW0c9qUS5iJ5raoBJiJqCkYKlYAVomrTmPnKumPBRX4eojQkWZIpJhWTZdEbe7OeiQ9yur27JPcA8-wJoySljjVRS_BfklKMZqRB8tQdv_Awul1RxwXAPuwtmrVHS6gmp839QeCJ-XagFUkb9rwazbwit9t4guU3Li293jlF3n7n7k7l7yNztMsfWlwfr2-sF4rHxEDICrw-A7wETar6E3I-ckVxarqbf3k21zA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20273656</pqid></control><display><type>article</type><title>Spectral frequency index monitoring during propofol-remifentanil and propofol-alfentanil total intravenous anaesthesia</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>ZABA, Zbigniew ; BIENERT, Agnieszka ; DROBNIK, Leon ; DYDERSKI, Stanislaw ; KUSZA, Krzysztof</creator><creatorcontrib>ZABA, Zbigniew ; BIENERT, Agnieszka ; DROBNIK, Leon ; DYDERSKI, Stanislaw ; KUSZA, Krzysztof</creatorcontrib><description>The aim of this study was to evaluate the usefulness of spectral frequency index (SFx) monitoring to assess the depth of anaesthesia during propofol-opioid total intravenous anaesthesia (TIVA). Thirty-three patients scheduled for laparoscopic cholecystectomy under propofol TIVA were prospectively and randomly allocated to receive either remifentanil (bolus of 1.0 microg/kg, followed by continuous infusion from 0.25 to 0.05 microg/kg/min) [n = 18] or alfentanil (bolus of 10 microg/kg, followed by continuous infusion from 2.0 to 0.5 microg/kg/min) [n = 15]. EEG activity was monitored to achieve the desired depth of anaesthesia, and intravenous propofol was titrated to keep the SFx at 70-80%. The remifentanil and alfentanil groups were compared in relation to the plasma propofol concentration required for an adequate level of hypnosis during maintenance of anaesthesia, Pearson correlation coefficient for the relationship between the plasma propofol concentration and SFx values, recovery parameters, and recall of events during anaesthesia. The study groups were comparable with regard to demographic characteristics, type and duration of surgery, and time to resumption of spontaneous ventilation. No evidence of explicit recall was noted. The mean plasma propofol concentration required for an adequate level of hypnosis during maintenance of anaesthesia was significantly higher in the alfentanil group (3.20 microg/mL) compared with the remifentanil group (2.17 microg/L) [p &lt; 0.05]. In both groups, the Pearson correlation coefficient test showed a linear correlation between SFx values and propofol concentration in the studied propofol concentration range. The mean time to orientation for name and place was significantly shorter (p &lt; 0.05), the mean propofol concentration at orientation for name and place and at the resumption of spontaneous ventilation timepoints was significantly lower (both p &lt; 0.01), and the mean SFx value at resumption of spontaneous ventilation timepoint was significantly higher (p &lt; 0.01) in the remifentanil group. As SFx is linearly related to plasma propofol concentration, this index may be used to measure anaesthetic effect during propofol anaesthesia. The results of this clinical trial are consistent with a previous computer-simulated opioid-propofol model with regard to intraoperative and recovery variables, although the recovery occurred at different propofol concentration and SFx values.</description><identifier>ISSN: 1172-7047</identifier><identifier>EISSN: 1179-1934</identifier><identifier>DOI: 10.2165/00023210-200721020-00006</identifier><identifier>PMID: 17284097</identifier><language>eng</language><publisher>Hong Kong: Adis International</publisher><subject>Adult ; Alfentanil - administration &amp; dosage ; Alfentanil - blood ; Anesthesia Recovery Period ; Anesthesia, Intravenous ; Anesthetics, Combined - administration &amp; dosage ; Anesthetics, Intravenous - administration &amp; dosage ; Anesthetics, Intravenous - blood ; Anesthetics. Neuromuscular blocking agents ; Biological and medical sciences ; Cholecystectomy, Laparoscopic ; Female ; Humans ; Male ; Medical sciences ; Middle Aged ; Monitoring, Physiologic ; Neuropharmacology ; Pharmacology. Drug treatments ; Piperidines - administration &amp; dosage ; Piperidines - blood ; Propofol - administration &amp; dosage ; Propofol - blood ; Spectrum Analysis</subject><ispartof>CNS drugs, 2007-01, Vol.21 (2), p.165-171</ispartof><rights>2007 INIST-CNRS</rights><rights>COPYRIGHT 2007 Wolters Kluwer Health, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-736f024da2708e15ed70e8541fc94e70f772ad22614ad7bcd788c9e5fdf6cf913</citedby><cites>FETCH-LOGICAL-c441t-736f024da2708e15ed70e8541fc94e70f772ad22614ad7bcd788c9e5fdf6cf913</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18525926$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17284097$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ZABA, Zbigniew</creatorcontrib><creatorcontrib>BIENERT, Agnieszka</creatorcontrib><creatorcontrib>DROBNIK, Leon</creatorcontrib><creatorcontrib>DYDERSKI, Stanislaw</creatorcontrib><creatorcontrib>KUSZA, Krzysztof</creatorcontrib><title>Spectral frequency index monitoring during propofol-remifentanil and propofol-alfentanil total intravenous anaesthesia</title><title>CNS drugs</title><addtitle>CNS Drugs</addtitle><description>The aim of this study was to evaluate the usefulness of spectral frequency index (SFx) monitoring to assess the depth of anaesthesia during propofol-opioid total intravenous anaesthesia (TIVA). Thirty-three patients scheduled for laparoscopic cholecystectomy under propofol TIVA were prospectively and randomly allocated to receive either remifentanil (bolus of 1.0 microg/kg, followed by continuous infusion from 0.25 to 0.05 microg/kg/min) [n = 18] or alfentanil (bolus of 10 microg/kg, followed by continuous infusion from 2.0 to 0.5 microg/kg/min) [n = 15]. EEG activity was monitored to achieve the desired depth of anaesthesia, and intravenous propofol was titrated to keep the SFx at 70-80%. The remifentanil and alfentanil groups were compared in relation to the plasma propofol concentration required for an adequate level of hypnosis during maintenance of anaesthesia, Pearson correlation coefficient for the relationship between the plasma propofol concentration and SFx values, recovery parameters, and recall of events during anaesthesia. The study groups were comparable with regard to demographic characteristics, type and duration of surgery, and time to resumption of spontaneous ventilation. No evidence of explicit recall was noted. The mean plasma propofol concentration required for an adequate level of hypnosis during maintenance of anaesthesia was significantly higher in the alfentanil group (3.20 microg/mL) compared with the remifentanil group (2.17 microg/L) [p &lt; 0.05]. In both groups, the Pearson correlation coefficient test showed a linear correlation between SFx values and propofol concentration in the studied propofol concentration range. The mean time to orientation for name and place was significantly shorter (p &lt; 0.05), the mean propofol concentration at orientation for name and place and at the resumption of spontaneous ventilation timepoints was significantly lower (both p &lt; 0.01), and the mean SFx value at resumption of spontaneous ventilation timepoint was significantly higher (p &lt; 0.01) in the remifentanil group. As SFx is linearly related to plasma propofol concentration, this index may be used to measure anaesthetic effect during propofol anaesthesia. The results of this clinical trial are consistent with a previous computer-simulated opioid-propofol model with regard to intraoperative and recovery variables, although the recovery occurred at different propofol concentration and SFx values.</description><subject>Adult</subject><subject>Alfentanil - administration &amp; dosage</subject><subject>Alfentanil - blood</subject><subject>Anesthesia Recovery Period</subject><subject>Anesthesia, Intravenous</subject><subject>Anesthetics, Combined - administration &amp; dosage</subject><subject>Anesthetics, Intravenous - administration &amp; dosage</subject><subject>Anesthetics, Intravenous - blood</subject><subject>Anesthetics. Neuromuscular blocking agents</subject><subject>Biological and medical sciences</subject><subject>Cholecystectomy, Laparoscopic</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Monitoring, Physiologic</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Piperidines - administration &amp; dosage</subject><subject>Piperidines - blood</subject><subject>Propofol - administration &amp; dosage</subject><subject>Propofol - blood</subject><subject>Spectrum Analysis</subject><issn>1172-7047</issn><issn>1179-1934</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkV1rFTEQhoMotlb_giyI3m1Nsvm8LMUvKHihXoc0mdTIbnJM9hT7752ec-xBECQXE948M7yTl5CB0XPOlHxLKeUTZ3TklGqsnI4oUfWInDKm7cjsJB7v7nzUVOgT8qz3H0iISamn5AR1I6jVp-T2ywbC2vw8pAY_t1DC3ZBLhF_DUktea8vlZojbXdm0uqmpzmODJScoqy95HnyJxxc_P-hrXXFqLjj8FkrddiQ99PU79OyfkyfJzx1eHOoZ-fb-3dfLj-PV5w-fLi-uxiAEW0c9qUS5iJ5raoBJiJqCkYKlYAVomrTmPnKumPBRX4eojQkWZIpJhWTZdEbe7OeiQ9yur27JPcA8-wJoySljjVRS_BfklKMZqRB8tQdv_Awul1RxwXAPuwtmrVHS6gmp839QeCJ-XagFUkb9rwazbwit9t4guU3Li293jlF3n7n7k7l7yNztMsfWlwfr2-sF4rHxEDICrw-A7wETar6E3I-ckVxarqbf3k21zA</recordid><startdate>20070101</startdate><enddate>20070101</enddate><creator>ZABA, Zbigniew</creator><creator>BIENERT, Agnieszka</creator><creator>DROBNIK, Leon</creator><creator>DYDERSKI, Stanislaw</creator><creator>KUSZA, Krzysztof</creator><general>Adis International</general><general>Wolters Kluwer Health, Inc</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>20070101</creationdate><title>Spectral frequency index monitoring during propofol-remifentanil and propofol-alfentanil total intravenous anaesthesia</title><author>ZABA, Zbigniew ; BIENERT, Agnieszka ; DROBNIK, Leon ; DYDERSKI, Stanislaw ; KUSZA, Krzysztof</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-736f024da2708e15ed70e8541fc94e70f772ad22614ad7bcd788c9e5fdf6cf913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adult</topic><topic>Alfentanil - administration &amp; dosage</topic><topic>Alfentanil - blood</topic><topic>Anesthesia Recovery Period</topic><topic>Anesthesia, Intravenous</topic><topic>Anesthetics, Combined - administration &amp; dosage</topic><topic>Anesthetics, Intravenous - administration &amp; dosage</topic><topic>Anesthetics, Intravenous - blood</topic><topic>Anesthetics. Neuromuscular blocking agents</topic><topic>Biological and medical sciences</topic><topic>Cholecystectomy, Laparoscopic</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Monitoring, Physiologic</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Piperidines - administration &amp; dosage</topic><topic>Piperidines - blood</topic><topic>Propofol - administration &amp; dosage</topic><topic>Propofol - blood</topic><topic>Spectrum Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ZABA, Zbigniew</creatorcontrib><creatorcontrib>BIENERT, Agnieszka</creatorcontrib><creatorcontrib>DROBNIK, Leon</creatorcontrib><creatorcontrib>DYDERSKI, Stanislaw</creatorcontrib><creatorcontrib>KUSZA, Krzysztof</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>CNS drugs</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ZABA, Zbigniew</au><au>BIENERT, Agnieszka</au><au>DROBNIK, Leon</au><au>DYDERSKI, Stanislaw</au><au>KUSZA, Krzysztof</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Spectral frequency index monitoring during propofol-remifentanil and propofol-alfentanil total intravenous anaesthesia</atitle><jtitle>CNS drugs</jtitle><addtitle>CNS Drugs</addtitle><date>2007-01-01</date><risdate>2007</risdate><volume>21</volume><issue>2</issue><spage>165</spage><epage>171</epage><pages>165-171</pages><issn>1172-7047</issn><eissn>1179-1934</eissn><abstract>The aim of this study was to evaluate the usefulness of spectral frequency index (SFx) monitoring to assess the depth of anaesthesia during propofol-opioid total intravenous anaesthesia (TIVA). Thirty-three patients scheduled for laparoscopic cholecystectomy under propofol TIVA were prospectively and randomly allocated to receive either remifentanil (bolus of 1.0 microg/kg, followed by continuous infusion from 0.25 to 0.05 microg/kg/min) [n = 18] or alfentanil (bolus of 10 microg/kg, followed by continuous infusion from 2.0 to 0.5 microg/kg/min) [n = 15]. EEG activity was monitored to achieve the desired depth of anaesthesia, and intravenous propofol was titrated to keep the SFx at 70-80%. The remifentanil and alfentanil groups were compared in relation to the plasma propofol concentration required for an adequate level of hypnosis during maintenance of anaesthesia, Pearson correlation coefficient for the relationship between the plasma propofol concentration and SFx values, recovery parameters, and recall of events during anaesthesia. The study groups were comparable with regard to demographic characteristics, type and duration of surgery, and time to resumption of spontaneous ventilation. No evidence of explicit recall was noted. The mean plasma propofol concentration required for an adequate level of hypnosis during maintenance of anaesthesia was significantly higher in the alfentanil group (3.20 microg/mL) compared with the remifentanil group (2.17 microg/L) [p &lt; 0.05]. In both groups, the Pearson correlation coefficient test showed a linear correlation between SFx values and propofol concentration in the studied propofol concentration range. The mean time to orientation for name and place was significantly shorter (p &lt; 0.05), the mean propofol concentration at orientation for name and place and at the resumption of spontaneous ventilation timepoints was significantly lower (both p &lt; 0.01), and the mean SFx value at resumption of spontaneous ventilation timepoint was significantly higher (p &lt; 0.01) in the remifentanil group. As SFx is linearly related to plasma propofol concentration, this index may be used to measure anaesthetic effect during propofol anaesthesia. The results of this clinical trial are consistent with a previous computer-simulated opioid-propofol model with regard to intraoperative and recovery variables, although the recovery occurred at different propofol concentration and SFx values.</abstract><cop>Hong Kong</cop><cop>Auckland</cop><pub>Adis International</pub><pmid>17284097</pmid><doi>10.2165/00023210-200721020-00006</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1172-7047
ispartof CNS drugs, 2007-01, Vol.21 (2), p.165-171
issn 1172-7047
1179-1934
language eng
recordid cdi_proquest_miscellaneous_68985654
source MEDLINE; SpringerNature Journals
subjects Adult
Alfentanil - administration & dosage
Alfentanil - blood
Anesthesia Recovery Period
Anesthesia, Intravenous
Anesthetics, Combined - administration & dosage
Anesthetics, Intravenous - administration & dosage
Anesthetics, Intravenous - blood
Anesthetics. Neuromuscular blocking agents
Biological and medical sciences
Cholecystectomy, Laparoscopic
Female
Humans
Male
Medical sciences
Middle Aged
Monitoring, Physiologic
Neuropharmacology
Pharmacology. Drug treatments
Piperidines - administration & dosage
Piperidines - blood
Propofol - administration & dosage
Propofol - blood
Spectrum Analysis
title Spectral frequency index monitoring during propofol-remifentanil and propofol-alfentanil total intravenous anaesthesia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T10%3A15%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Spectral%20frequency%20index%20monitoring%20during%20propofol-remifentanil%20and%20propofol-alfentanil%20total%20intravenous%20anaesthesia&rft.jtitle=CNS%20drugs&rft.au=ZABA,%20Zbigniew&rft.date=2007-01-01&rft.volume=21&rft.issue=2&rft.spage=165&rft.epage=171&rft.pages=165-171&rft.issn=1172-7047&rft.eissn=1179-1934&rft_id=info:doi/10.2165/00023210-200721020-00006&rft_dat=%3Cgale_proqu%3EA199865973%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20273656&rft_id=info:pmid/17284097&rft_galeid=A199865973&rfr_iscdi=true